These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30720133)

  • 1. Promoter hypermethylation of SOX11 promotes the progression of cervical cancer in vitro and in vivo.
    Li X; Wu X; Li Y; Cui Y; Tian R; Singh N; Ding M; Yang Y; Gao Y
    Oncol Rep; 2019 Apr; 41(4):2351-2360. PubMed ID: 30720133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoter hypermethylation of KLF4 inactivates its tumor suppressor function in cervical carcinogenesis.
    Yang WT; Zheng PS
    PLoS One; 2014; 9(2):e88827. PubMed ID: 24551169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation and histone modifications regulate SOX11 expression in lymphoid and solid cancer cells.
    Nordström L; Andersson E; Kuci V; Gustavsson E; Holm K; Ringnér M; Guldberg P; Ek S
    BMC Cancer; 2015 Apr; 15():273. PubMed ID: 25880212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
    Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
    Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CpG island promoter hypermethylation of Ras association domain family 1A gene contributes to gastric carcinogenesis.
    Joo MK; Kim KH; Park JJ; Yoo HS; Choe J; Kim HJ; Lee BJ; Kim JS; Bak YT
    Mol Med Rep; 2015 Apr; 11(4):3039-46. PubMed ID: 25483734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia.
    Steenbergen RD; Kramer D; Braakhuis BJ; Stern PL; Verheijen RH; Meijer CJ; Snijders PJ
    J Natl Cancer Inst; 2004 Feb; 96(4):294-305. PubMed ID: 14970278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant methylation‑mediated decrease of lncRNA HNF1A‑AS1 contributes to malignant progression of laryngeal squamous cell carcinoma via EMT.
    Shi Y; Zhang Q; Xie M; Feng Y; Ma S; Yi C; Wang Z; Li Y; Liu X; Liu H; Yang H; Yan Y; Zhang Y; Ren X; Luo H
    Oncol Rep; 2020 Dec; 44(6):2503-2516. PubMed ID: 33125127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant SOX11 promoter methylation is associated with poor prognosis in gastric cancer.
    Xu X; Chang X; Li Z; Wang J; Deng P; Zhu X; Liu J; Zhang C; Chen S; Dai D
    Cell Oncol (Dordr); 2015 Jun; 38(3):183-94. PubMed ID: 25801783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant promoter methylation and silencing of RASSF2A gene in cervical cancer.
    Zhang X; Ma Y; Wu Y; Lin L; Ma X; Zhang Y
    J Obstet Gynaecol Res; 2014 May; 40(5):1375-81. PubMed ID: 24605823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant promoter methylation and expression of UTF1 during cervical carcinogenesis.
    Guenin S; Mouallif M; Deplus R; Lampe X; Krusy N; Calonne E; Delbecque K; Kridelka F; Fuks F; Ennaji MM; Delvenne P
    PLoS One; 2012; 7(8):e42704. PubMed ID: 22880087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression analysis combined with functional genomics approach identifies ITIH5 as tumor suppressor gene in cervical carcinogenesis.
    Dittmann J; Ziegfeld A; Jansen L; Gajda M; Kloten V; Dahl E; Runnebaum IB; Dürst M; Backsch C
    Mol Carcinog; 2017 Jun; 56(6):1578-1589. PubMed ID: 28059468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium-coupled monocarboxylate transporter is a target of epigenetic repression in cervical cancer.
    Hernández-Juárez J; Vargas-Sierra O; Herrera LA; Cantú De León D; Fernández-Retana J; Pérez-Plasencia C; López-Camarillo C; Gariglio P; Díaz-Chávez J
    Int J Oncol; 2019 May; 54(5):1613-1624. PubMed ID: 30896789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic regulation of human riboflavin transporter 2(hRFT2) in cervical cancers from Uighur women.
    Ma JQ; Kurban S; Zhao JD; Li QZ; Hasimu A
    Asian Pac J Cancer Prev; 2014; 15(6):2485-9. PubMed ID: 24761851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IGSF4 promoter methylation and expression silencing in human cervical cancer.
    Li J; Zhang Z; Bidder M; Funk MC; Nguyen L; Goodfellow PJ; Rader JS
    Gynecol Oncol; 2005 Jan; 96(1):150-8. PubMed ID: 15589594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
    Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
    Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOXC transcription factors in mantle cell lymphoma: the role of promoter methylation in SOX11 expression.
    Wasik AM; Lord M; Wang X; Zong F; Andersson P; Kimby E; Christensson B; Karimi M; Sander B
    Sci Rep; 2013; 3():1400. PubMed ID: 23466598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SOX11 hypermethylation as a tumor biomarker in endometrial cancer.
    Shan T; Uyar DS; Wang LS; Mutch DG; Huang TH; Rader JS; Sheng X; Huang YW
    Biochimie; 2019 Jul; 162():8-14. PubMed ID: 30935961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypomethylation-associated Sox11 upregulation promotes oncogenesis via the PI3K/AKT pathway in OLP-associated OSCC.
    Liu Y; Cao P; Xiao L; Tang N; Fei W; Li X
    J Cell Mol Med; 2024 Jul; 28(14):e18556. PubMed ID: 39039706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
    Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
    Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter hypermethylation of SOX11 correlates with adverse clinicopathological features of human prostate cancer.
    Pugongchai A; Bychkov A; Sampatanukul P
    Int J Exp Pathol; 2017 Dec; 98(6):341-346. PubMed ID: 29315911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.